CVS Health Corporation $CVS Shares Sold by Beta Wealth Group Inc.

Beta Wealth Group Inc. lessened its position in shares of CVS Health Corporation (NYSE:CVS) by 81.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,123 shares of the pharmacy operator’s stock after selling 31,192 shares during the quarter. Beta Wealth Group Inc.’s holdings in CVS Health were worth $537,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Avion Wealth raised its stake in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares during the period. Harbor Capital Advisors Inc. grew its stake in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares in the last quarter. Corundum Trust Company INC acquired a new stake in CVS Health in the third quarter valued at approximately $29,000. Front Row Advisors LLC lifted its position in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in shares of CVS Health during the 2nd quarter worth about $36,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of research reports. Robert W. Baird upped their target price on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Evercore raised their price target on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Argus cut their price objective on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Barclays increased their price target on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Finally, JPMorgan Chase & Co. increased their target price on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Nineteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $94.91.

CVS Health Price Performance

Shares of CVS Health stock opened at $78.45 on Tuesday. The business’s fifty day moving average price is $78.68 and its 200 day moving average price is $76.45. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $99.80 billion, a P/E ratio of 56.85, a PEG ratio of 0.82 and a beta of 0.50.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same period last year, the business posted $1.19 EPS. The company’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date was Thursday, January 22nd. CVS Health’s payout ratio is currently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.